ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,703.57
      0.33%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Prothena Corporation PLC (PRTA)

      7. Prothena Corporation PLC (PRTA) News

      PRTA

      Prothena (PRTA)

      Prothena Corporation PLC
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRTA
      DateTimeSourceHeadlineSymbolCompany
      05/28/20244:05PMBusiness WireProthena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development CollaborationNASDAQ:PRTAProthena Corporation PLC
      05/17/20244:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      05/17/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      05/17/20244:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      05/17/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
      05/08/20244:19PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRTAProthena Corporation PLC
      05/08/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
      05/08/20244:05PMBusiness WireProthena Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
      05/01/20244:05PMBusiness WireProthena to Report First Quarter 2024 Financial Results on May 8NASDAQ:PRTAProthena Corporation PLC
      04/15/20244:05PMBusiness WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & LymphomaNASDAQ:PRTAProthena Corporation PLC
      03/05/20249:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      03/05/20249:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      03/05/20244:05PMBusiness WireProthena to Participate in Upcoming Healthcare ConferencesNASDAQ:PRTAProthena Corporation PLC
      03/04/20244:05PMBusiness WireProthena Appoints David Ford to Newly Created Chief People Officer PositionNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/29/20249:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTAProthena Corporation PLC
      02/22/20245:29PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PRTAProthena Corporation PLC
      02/22/20244:56PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRTAProthena Corporation PLC
      02/21/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
      02/21/20244:05PMBusiness WireProthena Announces Appointment of Daniel G. Welch as Director and Chair DesignateNASDAQ:PRTAProthena Corporation PLC
      02/15/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRTAProthena Corporation PLC
      02/15/20244:05PMBusiness WireProthena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business HighlightsNASDAQ:PRTAProthena Corporation PLC
      02/14/202412:16PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTAProthena Corporation PLC
       Showing the most relevant articles for your search:NASDAQ:PRTA